Showing results (1851-1860 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|May 31, 2023
Comparing how well abrocitinib and dupilumab treat atopic dermatitis signs and symptoms: a plain language summaryKristian Reich, Jacob P Thyssen, Andrew Blauvelt, et al.Immunotherapy|November 28, 2024
Economics of first-line treatment with tislelizumab in patients with nonsquamous non-small cell lung cancerLin Wang, Ting Liu, Xihan Lin, et al.Immunotherapy|December 2, 2024
Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscapeAlexander Röth, Austin G Kulasekararaj, Phillip Scheinberg, et al.Immunotherapy|May 25, 2026
CAR-iNKT cells for cancer therapy: a comprehensive review of engineering, mechanisms, and clinical progressYing Yang, Jiaqi Gu, Yujie Ding, et al.Immunotherapy|May 4, 2026
Next-generation cancer immunotherapy: the promise of CAR T-Cell therapyHarshad S Kapare, Rutuja Jadhav, Pawan N Karwa, et al.Immunotherapy|May 27, 2026
Disrupting neuro-immune feedback loops: novel targets to amplify cancer immunotherapyAbbas Jafari, Kovsar Mohammadnezhadharmileh, Maryam Majidinia, et al.Immunotherapy|March 18, 2026
Immunotherapy of endometrial cancer: a review of recent advancesKrešimir Tomić, Kristina Katić, Zoran Gatalica, et al.Immunotherapy|March 12, 2026
Neoadjuvant immune checkpoint inhibitors for muscle-invasive urothelial carcinoma: a systematic review and meta-analysisAna Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Luana Diniz Guerra Braz, et al.Immunotherapy|March 3, 2026
Financial barriers to immunotherapy: challenges and potential mitigation strategies: a review paperHasan Numan, Arafat TfayliImmunotherapy|June 12, 2026
Refining adjuvant therapy options in patients with stage II melanomaBryant Morocho, Sasha Lightfoot, Ponnandai Somasundar, et al.Pageof 190